Wayne P. Rothbaum - Net Worth and Insider Trading

Wayne P. Rothbaum Net Worth

The estimated net worth of Wayne P. Rothbaum is at least $338 Million dollars as of 2024-04-30. Wayne P. Rothbaum is the Director of Iovance Biotherapeutics Inc and owns about 28,067,333 shares of Iovance Biotherapeutics Inc (IOVA) stock worth over $338 Million. Details can be seen in Wayne P. Rothbaum's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Wayne P. Rothbaum has not made any transactions after 2024-02-20 and currently still holds the listed stock(s).

Transaction Summary of Wayne P. Rothbaum

To

Wayne P. Rothbaum Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Wayne P. Rothbaum owns 1 companies in total, including Iovance Biotherapeutics Inc (IOVA) .

Click here to see the complete history of Wayne P. Rothbaum’s form 4 insider trades.

Insider Ownership Summary of Wayne P. Rothbaum

Ticker Comapny Transaction Date Type of Owner
IOVA Iovance Biotherapeutics Inc 2024-02-20 director

Wayne P. Rothbaum Latest Holdings Summary

Wayne P. Rothbaum currently owns a total of 1 stock. Wayne P. Rothbaum owns 28,067,333 shares of Iovance Biotherapeutics Inc (IOVA) as of February 20, 2024, with a value of $338 Million.

Latest Holdings of Wayne P. Rothbaum

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
IOVA Iovance Biotherapeutics Inc 2024-02-20 28,067,333 12.03 337,650,016

Holding Weightings of Wayne P. Rothbaum


Wayne P. Rothbaum Form 4 Trading Tracker

According to the SEC Form 4 filings, Wayne P. Rothbaum has made a total of 4 transactions in Iovance Biotherapeutics Inc (IOVA) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Iovance Biotherapeutics Inc is the acquisition of 5,000,000 shares on February 20, 2024, which cost Wayne P. Rothbaum around $46 Million.

Insider Trading History of Wayne P. Rothbaum

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Wayne P. Rothbaum Trading Performance

GuruFocus tracks the stock performance after each of Wayne P. Rothbaum's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Wayne P. Rothbaum is 31.33%. GuruFocus also compares Wayne P. Rothbaum's trading performance to market benchmark return within the same time period. The performance of stocks bought by Wayne P. Rothbaum within 3 months outperforms 3 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Wayne P. Rothbaum's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Wayne P. Rothbaum

Average Return

58.93%

Average return per transaction

Outperforming Transactions

67%

2 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 12.39 31.33 69.68 58.93 108.36 19.36
Relative Return to S&P 500(%) 15.64 30.49 63.42 48.11 91.2 -0.04

Wayne P. Rothbaum Ownership Network

Ownership Network List of Wayne P. Rothbaum

No Data

Ownership Network Relation of Wayne P. Rothbaum


Wayne P. Rothbaum Owned Company Details

What does Iovance Biotherapeutics Inc do?

Who are the key executives at Iovance Biotherapeutics Inc?

Wayne P. Rothbaum is the director of Iovance Biotherapeutics Inc. Other key executives at Iovance Biotherapeutics Inc include General Counsel Frederick G Vogt , Chief Operating Officer Igor Bilinsky , and Chief Financial Officer Jean-marc Bellemin .

Iovance Biotherapeutics Inc (IOVA) Insider Trades Summary

Over the past 18 months, Wayne P. Rothbaum made 3 insider transaction in Iovance Biotherapeutics Inc (IOVA) with a net purchase of 20,000,000. Other recent insider transactions involving Iovance Biotherapeutics Inc (IOVA) include a net purchase of 290,000 shares made by Merrill A Mcpeak , a net purchase of 10,000 shares made by Iain D. Dukes , and a net purchase of 1,000 shares made by Frederick G Vogt .

In summary, during the past 3 months, insiders sold 0 shares of Iovance Biotherapeutics Inc (IOVA) in total and bought 5,250,000 shares, with a net purchase of 5,250,000 shares. During the past 18 months, 0 shares of Iovance Biotherapeutics Inc (IOVA) were sold and 20,301,000 shares were bought by its insiders, resulting in a net purchase of 20,301,000 shares.

Iovance Biotherapeutics Inc (IOVA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Iovance Biotherapeutics Inc Insider Transactions

No Available Data

Wayne P. Rothbaum Mailing Address

Above is the net worth, insider trading, and ownership report for Wayne P. Rothbaum. You might contact Wayne P. Rothbaum via mailing address: C/o Quogue Capital Llc, 1285 Avenue Of The Americas, 35th Floor, New York Ny 10019.

Discussions on Wayne P. Rothbaum

No discussions yet.